Ozonized Olive Oil in the Treatment of Periodontal Pockets

May 16, 2025 updated by: Massimo Petruzzi, University of Bari

Clinical and Microbiological Study on Local Application of an Ozonated Olive Oil Gel in the Periodontal Pockets: a Randomized Double-blind Trial.

A randomized controlled clinical trial was conducted on 16 patients (8 males and 8 women) who were diagnosed chronic periodontitis. All the patients has been divided by randomization in two groups: control group treated with placebo gel and experimental group treated with gel based on ozonated EVO olive oil.

Both group after the evaluation of inclusion and exclusion criteria during the first visit, were subjected to hygiene treatment of removal tartar deposit, considered as standard of therapy for periodontitis.

After 15 days the hygiene treatment, patients were been randomized in two groups following the flow chart (t0) starting with: periodontal probing, microbiological samples and the first administration of gel. Next week (t1), has been collected the compliance and did the second administration of gel; the procedures will be the same also for another week (t2), until the last week (t3) when has been registered the second periodontal probing and did the second microbiological samples.

Data were collected to software Microsoft Excel and all the data analysis were conducted on this software to highlight significant differences between both groups. As the primary outcome was continuous variable and assuming normal distribution bilateral parametric test T-student was performed. An alpha error of 5% was considered, Beta error was not calculated as this was a pilot study.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • BA
      • Bari, BA, Italy, 70124
        • Recruiting
        • Odontostomatologic Departement of Policlinic of Bari
        • Contact:
        • Sub-Investigator:
          • Fabio Vittorio Ciccone, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Patients with stage II, III, or IV periodontitis according to the new 2017 World Workshop periodontal classification
  • Patients of either sex and older than 18 years of age
  • Probing Pocket Depth (PPD) greater than or equal to 4 mm at 3 sites
  • Patients who have signed consent to the study
  • Collaborating patients

Exclusion Criteria:

  • age < 18 years and/or inability to provide written informed consent;
  • absence of family or social welfare support;
  • non-drug-induced gingival hypertrophy,
  • severe smokers (more than 20 cigarettes per day),
  • consumers of high levels of alcohol,
  • patients on corticosteroid treatment,
  • diabetic patient,
  • immunodepressive therapies,
  • chemotherapies,
  • radiotherapies,
  • pregnancy states;
  • lack of collaboration for ongoing postoperative reevaluations.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Ozonized Olive Oil Intervention Group
It has been administrated in the form of gel once a week for three weeks
It is a natural oil which has been ozonized to improve the antimicrobial activity against periodontopathogenic bacterias
Placebo Comparator: Placebo Controlled Group
Same description of Interventional Group
Placebo gel with same texture, color, way of administration and taste of Activated Ozonized Olive Oil Gel

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference of Probing Pocket Depth (PPD)
Time Frame: One measure to assess inclusion, second mesure at randomization and third measure after 21 days
It is a measures in mm assessed with periodontal probe in periodontal pockets
One measure to assess inclusion, second mesure at randomization and third measure after 21 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference of Total microbial load
Time Frame: One measure at randomization and second measure after 21 days
Expressed in percentage, samples performed with sterile paper cone and measurement performed with Applied Biosystem 7500 sequence detection system with Real Time PCR
One measure at randomization and second measure after 21 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Massimo Petruzzi, PhD, MD, University of Bari

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 25, 2021

Primary Completion (Actual)

November 1, 2024

Study Completion (Estimated)

May 1, 2025

Study Registration Dates

First Submitted

May 25, 2024

First Submitted That Met QC Criteria

May 16, 2025

First Posted (Estimated)

May 20, 2025

Study Record Updates

Last Update Posted (Estimated)

May 20, 2025

Last Update Submitted That Met QC Criteria

May 16, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 7493 (Cleveland Clinic IRB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontal Pocket

Clinical Trials on Activated Ozonized Olive Oil Gel

Subscribe